GLS and pancreatic neoplasm: Finally, researchers have found that antisense LNC RNA-GLS-AS, which is negatively correlated with GLS1 expression in clinical pancreatic cancer samples, can form double-stranded RNA with GLS1 pre-mRNA through ADAR/Dicer-dependent RNA interference and inhibit GLS1 expression at the post-transcriptional level.